Chemotherapeutic Sensitization of Leptomycin B Resistant Lung Cancer Cells by Pretreatment with Doxorubicin

The development of novel targeted therapies has become an important research focus for lung cancer treatment. Our previous study has shown leptomycin B (LMB) significantly inhibited proliferation of lung cancer cells; however, p53 wild type lung cancer cells were resistant to LMB. Therefore, the obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chuanwen, Shao, Changxia, Cobos, Everardo, Singh, Kamaleshwar P., Gao, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296751/
https://www.ncbi.nlm.nih.gov/pubmed/22412944
http://dx.doi.org/10.1371/journal.pone.0032895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296751/
https://www.ncbi.nlm.nih.gov/pubmed/22412944
http://dx.doi.org/10.1371/journal.pone.0032895

Ejemplares similares